An open-label phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 Gangliosidosis (Tay-Sachs or Sandhoff variants)

✍ Scribed by Joe Clarke; Don Mahuran; Swati Sathe; Edwin Kolodny; Brigitte Rigat; Julian Raiman; Michael Tropak

• Book ID: 116989137
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 56 KB
• Volume: 102
• Category: Article
• ISSN: 1096-7192
• DOI: 10.1016/j.ymgme.2010.11.040